AGENDA

FRIDAY, OCTOBER 30, 2020

12:00 – 12:50 PM

Lunch

12:50 – 1:00 PM

Welcome / Introduction

SESSION I

1:00 – 1:30 PM

Hepatitis C: Expanding Indications, Black Box Warnings and Screening

Nancy Reau, MD

1:30 – 2:00 PM

ASH vs. NASH: Similarities and Differences

Craig McClain, MD

2:00 – 2:55 PM

Complications of Portal Hypertension: Management Options for Hepatic Encephalopathy, Thrombocytopenia, and Hepatorenal Syndrome

Mack Mitchell, MD and Santiago Munoz, MD

2:55 – 3:15 PM

Q&A / Panel Discussion

3:15 – 3:30 PM

Break

SESSION II

3:30 – 4:00 PM

Practical Management of Clostridioides Difficile: Not so Difficile? 

Lawrence Schiller, MD

4:00 – 4:25 PM

Microbiome Based Treatments for IBS: Food, Bugs, or Drugs

William Chey, MD

4:25 – 4:50 PM

Management of Diverticulitis

Brennan Spiegel, MD

4:50 – 5:15 PM

Q&A / Panel Discussion

5:15 – 5:30 PM

Day 1 Wrap-up

5:30 – 7:00 PM

Welcome Reception

SATURDAY, OCTOBER 31, 2020

7:30 – 8:20 AM

Breakfast

8:20 – 8:30 AM

Welcome

SESSION III

8:30 – 9:00 AM

How Opioid Use Might Impact Esophageal Symptoms and Motility 

Michael Vaezi, MD

9:00 – 9:30 AM

GERD and Sleep: An Eye-opening Experience

Ronnie Fass, MD

9:30 – 10:00 AM

Endoscopic Management of Chronic Pancreatitis

Rajesh Rasik Shah, MD

10:00 – 10:30 AM

Q&A / Panel Discussion

10:30 – 10:45 AM

Break

10:45 – 11:45 AM

Parallel Sessions

(Attendees select one of the following)

  • Inflammatory Bowel Disease (IBD)

  • GI Woes from Head to Toe (Non-IBD)

  • Viral Hepatitis, Cholestatic Disease and Complications of Cirrhosis

  • Alcoholic and Non-Alcoholic Fatty Liver Disease

12:00 PM – 12:50 PM

Lunch

SESSION IV

1:00 – 1:25 PM

Practical Applications of Treat to Target in Inflammatory Bowel Disease (IBD)

Gary Lichtenstein, MD

1:25 – 1:50 PM

Managing Post-operative Crohn's Disease

David Binion MD, AGAF, FACG

1:50 – 2:15 PM

Health Care Maintenance in IBD

Francis Farraye, MD

2:15 – 2:40 PM

Managing Fertility and Pregnancy in IBD

Anita Afzali, MD

2:40 – 3:05 PM

Q&A / Panel Discussion

3:05 – 3:20 PM

Break

SESSION V

3:20 – 3:50 PM

Primary Biliary Cholangitis (PBC): Diagnosis and Treatment

Marlyn Mayo, MD

3:50 – 4:20 PM

Hepatocellular Carcinoma: Diagnosis and Treatment

Hashem El-Serag, MD

4:20 – 4:40 PM

Q&A / Panel Discussion

4:40 – 4:45 PM

Closing Remarks

This activity is supported by educational grants from AbbVie, Allergan Inc., Dova Pharmaceuticals, Gilead, Intercept Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, Salix Pharmaceuticals and Takeda Pharmaceuticals U.S.A., Inc.

Jointly provided by the Annenberg Center for Health Sciences 
at Eisenhower, the Gastrointestinal and Liver Association of the Americas (GALA), and the Texas Liver Institute.

  • Facebook Social Icon
  • Twitter Social Icon

© 2020 GI and Liver Association of the Americas